US 10071095
1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders
granted A61KA61K31/437A61K31/438
Quick answer
US patent 10071095 (1,2,4-triazolo [4,3-A] pyridine derivatives and their use for the treatment of neurological and psychiatric disorders) held by Addex Pharma, S.A. expires Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Addex Pharma, S.A.
- Grant date
- Tue Sep 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 06 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/437, A61K31/438, A61K31/4545, A61K31/496